Strongyloidiasis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(34 intermediate revisions by 8 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Strongyloidiasis}}
{{Strongyloidiasis}}
{{CMG}}
{{CMG}}; {{AE}} {{ADG}}
 
==Overview==
The global [[prevalence]] of ''[[Strongyloides]]'' is unknown, but experts estimate that there are between 30–100 million infected persons worldwide, mainly in tropical and subtropical countries. Strongyloidiasis infection is more common in the [[pediatric]] age group (ages 2-10 years).
 
==Epidemiology and Demographics==
==Epidemiology and Demographics==
It is thought to affect 30–100 million people worldwide, mainly in tropical and subtropical countries.
==== Prevalence====
*The global [[prevalence]] of ''[[Strongyloides]]'' is unknown, but recent studies estimate that there are between 30–100 million infected persons worldwide.
 
====Incidence====
*The incidence of strongyloidiasis is approximately 600-1,000 per 100,000 individuals in the United States.
*The incidence of strongyloidiasis is approximately 460-1,000 per 100,000 individuals in immigrant populations.
 
====Geographic distribution====
*''[[Strongyloides]]'' is known to exist on all continents except for Antarctica, but it is most common in the tropics, subtropics, and in warm temperate regions.


Tropical and subtropical areas, but cases also occur in temperate areas (including the South of the United States). More frequently found in rural areas, institutional settings, and lower socioeconomic groups. <ref>http://www.dpd.cdc.gov/dpdx/HTML/Strongyloidiasis.htm</ref>
===Age===
*[[Strongyloidiasis]] occurs in all age groups but it is more common in the [[pediatric]] age group (ages 2-10 years).


This infection is uncommon in the United States. Most cases seen in North America are brought by travelers who have visited or lived in South America or Africa.
===Gender===
*Males are more commonly affected by strongyloidiasis than females.
*The male to female ratio is approximately 2-3 to 1.<ref name="pmid24766337">{{cite journal |vauthors=Jongwutiwes U, Waywa D, Silpasakorn S, Wanachiwanawin D, Suputtamongkol Y |title=Prevalence and risk factors of acquiring Strongyloides stercoralis infection among patients attending a tertiary hospital in Thailand |journal=Pathog Glob Health |volume=108 |issue=3 |pages=137–40 |year=2014 |pmid=24766337 |pmc=4083175 |doi=10.1179/2047773214Y.0000000134 |url=}}</ref>
 
===Race===
*There is no racial predilection to strongyloidiasis.


==References==
==References==
Line 13: Line 31:
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs overview]]
{{WH}}
{{WS}}
 
[[Category:Disease]]
[[Category:Disease]]
[[Category:Emergency mdicine]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
 
[[Category:Gastroenterology]]
{{WH}}
[[Category:Dermatology]]
{{WS}}
[[Category:Neurology]]
[[Category:Pulmonology]]

Latest revision as of 00:19, 30 July 2020

Strongyloidiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Strongyloidiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Strongyloidiasis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Strongyloidiasis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Strongyloidiasis epidemiology and demographics

CDC on Strongyloidiasis epidemiology and demographics

Strongyloidiasis epidemiology and demographics in the news

Blogs on Strongyloidiasis epidemiology and demographics

Directions to Hospitals Treating Strongyloidiasis

Risk calculators and risk factors for Strongyloidiasis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

The global prevalence of Strongyloides is unknown, but experts estimate that there are between 30–100 million infected persons worldwide, mainly in tropical and subtropical countries. Strongyloidiasis infection is more common in the pediatric age group (ages 2-10 years).

Epidemiology and Demographics

Prevalence

  • The global prevalence of Strongyloides is unknown, but recent studies estimate that there are between 30–100 million infected persons worldwide.

Incidence

  • The incidence of strongyloidiasis is approximately 600-1,000 per 100,000 individuals in the United States.
  • The incidence of strongyloidiasis is approximately 460-1,000 per 100,000 individuals in immigrant populations.

Geographic distribution

  • Strongyloides is known to exist on all continents except for Antarctica, but it is most common in the tropics, subtropics, and in warm temperate regions.

Age

Gender

  • Males are more commonly affected by strongyloidiasis than females.
  • The male to female ratio is approximately 2-3 to 1.[1]

Race

  • There is no racial predilection to strongyloidiasis.

References

  1. Jongwutiwes U, Waywa D, Silpasakorn S, Wanachiwanawin D, Suputtamongkol Y (2014). "Prevalence and risk factors of acquiring Strongyloides stercoralis infection among patients attending a tertiary hospital in Thailand". Pathog Glob Health. 108 (3): 137–40. doi:10.1179/2047773214Y.0000000134. PMC 4083175. PMID 24766337.

Template:WH Template:WS